Françoise Solly, Fanny Angelot, Richard Garand, Christophe Ferrand, Estelle Seillès, et al.. CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry..
Cytometry Part A, Wiley, 2012, 81 (1), pp.17-24.
⟨10.1002/cyto.a.21162⟩.
⟨inserm-00799678⟩